Gechijian, Lara N. http://orcid.org/0000-0003-3226-5778
Buckley, Dennis L.
Lawlor, Matthew A.
Reyes, Jaime M.
Paulk, Joshiawa
Ott, Christopher J.
Winter, Georg E.
Erb, Michael A.
Scott, Thomas G.
Xu, Mousheng
Seo, Hyuk-Soo
Dhe-Paganon, Sirano
Kwiatkowski, Nicholas P.
Perry, Jennifer A.
Qi, Jun
Gray, Nathanael S. http://orcid.org/0000-0001-5354-7403
Bradner, James E. http://orcid.org/0000-0002-2718-4415
Article History
Received: 29 June 2017
Accepted: 5 January 2018
First Online: 5 March 2018
Change Date: 8 August 2018
Change Type: Update
Change Details: In the version of this article originally published, numbered compounds were not linked correctly to their respective compound pages. The error has been corrected in the HTML version of this paper.
Competing interests
: D.L.B. and J.P. are now employees of Novartis. N.S.G. is a Scientific Founder and member of the Scientific Advisory Board of C4 Therapeutics. J.E.B. is a Scientific Founder of C4 Therapeutics. J.E.B. is now an executive and shareholder in Novartis AG.